Sky Century Investment (SKYI) Liabilities and Shareholders Equity (2012 - 2026)
Sky Century Investment (SKYI) reported Liabilities and Shareholders Equity of $108586.0 for Q1 2026, up 70.04% year-over-year from $63858.0 in Q1 2025, and down 4.35% quarter-over-quarter from $113523.0 in Q4 2025.
Sky Century Investment (SKYI) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $108586.0 in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $108586.0, up 70.04% year-over-year; the trailing twelve-month figure through Feb 2026 was $458288.0 (up 187.79% YoY), and the FY2025 annual result was $111742.0, up 17.15% from the prior year.
- Liabilities and Shareholders Equity declined to $108586.0 in Q1 2026 per SKYI's latest filing, from $113523.0 in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $124437.0 in Q2 2025 and troughed at $63858.0 in Q1 2025.
- A 3-year average of $102921.7 and a median of $110164.0 in 2025 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity advanced 17.15% in 2025, then soared 70.04% in 2026.
- A 3-year view of Liabilities and Shareholders Equity shows it stood at $95384.0 in 2024, then climbed by 19.02% to $113523.0 in 2025, then decreased by 4.35% to $108586.0 in 2026.
- Business Quant data shows SKYI's Liabilities and Shareholders Equity at $108586.0 in Q1 2026, $113523.0 in Q4 2025, and $111742.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.27 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.35 Bn |
| 10 | Sky Century Investment | - | - | 31,666.00 | 108,586.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 108,586.00 |
| Nov 30, 2025 | 113,523.00 |
| Aug 31, 2025 | 111,742.00 |
| May 31, 2025 | 124,437.00 |
| Feb 28, 2025 | 63,858.00 |
| Aug 31, 2024 | 95,384.00 |
| Aug 31, 2014 | 515.00 |
| May 31, 2014 | 515.00 |
| Feb 28, 2014 | 515.00 |
| Nov 30, 2013 | 5,565.00 |
| Aug 31, 2013 | 479.00 |
| May 31, 2013 | 154.00 |
| May 31, 2012 | 5,000.00 |